CBER chief Prasad details why he overrode Novavax reviewersnews2025-06-30T17:26:07+00:00June 30th, 2025|Endpoints News|
Hikma pledges $1B to expand US manufacturing presencenews2025-06-30T11:12:49+00:00June 30th, 2025|Endpoints News|
Unicycive gets a CRL for chronic kidney disease pill as third-party production issues lingernews2025-06-30T11:05:19+00:00June 30th, 2025|Endpoints News|
Moderna reports Phase 3 flu data, teeing up new submissionsnews2025-06-30T11:00:29+00:00June 30th, 2025|Endpoints News|
J&J dealt blow in fight over its 340B rebate modelnews2025-06-27T18:57:03+00:00June 27th, 2025|Endpoints News|
FDA extends impurity data submission deadline for drugmakersnews2025-06-27T17:47:17+00:00June 27th, 2025|Endpoints News|
Innovent brings a new mechanism to obesity market with China approvalnews2025-06-27T14:28:44+00:00June 27th, 2025|Endpoints News|
A dinner in Paris revived talks for Sanofi’s $9.5B deal for Blueprintnews2025-06-27T09:09:43+00:00June 27th, 2025|Endpoints News|
Gilead ends RSV antiviral trials after low incidence ratesnews2025-06-26T19:04:57+00:00June 26th, 2025|Endpoints News|
Judge says CVS Caremark owes $95M in false claims casenews2025-06-26T18:49:30+00:00June 26th, 2025|Endpoints News|
